Clinical Trial Update: A Study Evaluating Potential Disease-Mediated Drug-Drug Interaction in Adult Participants With Active Eosinophilic Esophagitis Receiving Cendakimab [Phase 1]

View source ↗

Summary

Phase 1 trial evaluating potential disease-mediated drug-drug interaction in adults with active eosinophilic esophagitis treated with cendakimab has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Eosinophilic Esophagitis

Drugs mentioned

• Cendakimab (cendakimab)

Snippet

Sponsor: Celgene | Conditions: Eosinophilic Esophagitis | Phase 1 | Status: COMPLETED